|
April 12, 2022
|
Progenity to Become Biora Therapeutics as it Completes Transformation
|
|
April 6, 2022
|
Progenity Announces Two Poster Presentations at Controlled Release Society 2022
|
|
March 28, 2022
|
Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
|
|
March 16, 2022
|
Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update
|
|
March 10, 2022
|
Progenity Progresses its Drug Delivery System Clinical Device Performance Studies
|
|
February 28, 2022
|
Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022
|
|
February 22, 2022
|
Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO’22
|
|
February 16, 2022
|
Progenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
|
|
January 25, 2022
|
Progenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional Patent
|
|
January 11, 2022
|
Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
|